Research programme: fagaronine analogues - SIDR

Drug Profile

Research programme: fagaronine analogues - SIDR

Alternative Names: Fagaronine analogues research programme - SIDR; Fagaronine analogues research programme - Strathclyde Institute for Drug Research; Research programme: fagaronine analogues - Strathclyde Institute for Drug Research

Latest Information Update: 05 Feb 2008

Price : $50

At a glance

  • Originator Strathclyde Institute for Drug Research
  • Class Alkaloids; Phenanthridines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Glioma; Malignant melanoma

Most Recent Events

  • 20 Jul 1999 This programme is available for licensing (http://www.sidr.org)
  • 20 Jul 1999 Preclinical development for Malignant melanoma in United Kingdom (Unknown route)
  • 20 Jul 1999 Preclinical development for Glioma in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top